cdc25A is necessary but not sufficient for optimal c-myc-induced apoptosis and cell proliferation of vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Circulation Research

• Publication date

  1999-04-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.84.7.820PMID 10205150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade.

  1998cited by this paper
• Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

  1998cited by this paper
• Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis.

  1997cited by this paper
• Distinct roles for E2F proteins in cell growth control and apoptosis.

  1997cited by this paper
• S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.

  1997cited by this paper
• Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB

  1997cited by this paper
• Regulation of apoptosis by viral gene products

  1997cited by this paper
• Induction of DNA synthesis and apoptosis are separable functions of E2F-1.

  1997influential reference
• Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F

  1997cited by this paper
• E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

  1997cited by this paper
• c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.

  1996cited by this paper
• S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase.

  1996cited by this paper
• Signal Transduction Pathways Regulated by Mitogen-activated/Extracellular Response Kinase Kinase Kinase Induce Cell Death (*)

  1996cited by this paper
• Cdc25 cell-cycle phosphatase as a target of c-myc

  1996cited by this paper
• Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD.

  1996cited by this paper
• Modulation of c-Myc activity and apoptosis in vivo.

  1996cited by this paper
• Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.

  1996cited by this paper
• Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes.

  1995cited by this paper
• Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways.

  1995cited by this paper
• Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

  1995cited by this paper
• E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis

  1995cited by this paper
• Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques.

  1995cited by this paper
• Apoptosis and the cell cycle.

  1995cited by this paper
• Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.

  1995cited by this paper
• Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1.

  1995cited by this paper
• Apoptosis and the cell cycle

  1995cited by this paper
• Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?

  1994cited by this paper
• Transcatheter Delivery of c‐myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury

  1994cited by this paper
• Activation of cyclin A-dependent protein kinases during apoptosis.

  1994cited by this paper
• Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis

  1994cited by this paper
• Activation of the phosphatase activity of human cdc25A by a cdk2‐cyclin E dependent phosphorylation at the G1/S transition.

  1994cited by this paper
• Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis.

  1994cited by this paper
• Mediation of c-Myc-induced apoptosis by p53.

  1994cited by this paper
• p53 and E2F-1 cooperate to mediate apoptosis.

  1994cited by this paper
• Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis

  1994cited by this paper
• Cdc25A is a novel phosphatase functioning early in the cell cycle.

  1994cited by this paper
• c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.

  1994cited by this paper
• Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.

  1994cited by this paper
• Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.

  1994cited by this paper
• Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.

  1994cited by this paper
• p53-mediated cell death: relationship to cell cycle control

  1993cited by this paper
• The role of c-myc in cell growth.

  1993cited by this paper
• c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.

  1993cited by this paper
• The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max.

  1993cited by this paper
• Expression of transcription factor E2F1 induces quiescent cells to enter S phase

  1993cited by this paper
• Oncogenic activity of the c-Myc protein requires dimerization with Max.

  1993cited by this paper
• Cooperative interaction between c-myc and bcl-2 proto-oncogenes

  1992cited by this paper
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992cited by this paper
• Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

  1992cited by this paper
• Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty?

  1992cited by this paper
• Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max

  1992cited by this paper
• Apoptotic cell death induced by c-myc is inhibited by bcl-2

  1992cited by this paper
• The MYC protein activates transcription of the alpha‐prothymosin gene.

  1991cited by this paper
• Role of E2F transcription factor in E1A-mediated trans activation of cellular genes

  1991cited by this paper
• Gene Transfer and Expression Protocols

  1991cited by this paper
• c-myc protein expression in untransformed fibroblasts.

  1991cited by this paper
• Choice and manipulation of retroviral vectors.

  1991cited by this paper
• Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal.

  1990cited by this paper
• E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

  1989cited by this paper
• Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells

  1989cited by this paper

• BMAL1 insufficiency increases the risk of thoracic aortic aneurysm and dissection.

  2025cites this paper
• Tudor-SN exacerbates pathological vascular remodeling by promoting the polyubiquitination of PTEN via NEDD4-1

  2024cites this paper
• BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer

  2021cites this paper
• Curcumin shifts RAS ‐ induced pro ‐ proliferative MEK/ERK ‐ signaling toward pro ‐ apoptotic p38MAPK/JNK1 ‐ signaling, triggering p53 activation and apoptosis

  2017cites this paper
• Regulation of cancer cell death by a novel compound, C604, in a c-Myc-overexpressing cellular environment.

  2015cites this paper
• The role of Cdc25A in the regulation of cell proliferation and apoptosis.

  2012cites this paper
• Overexpression of Mitochondrial Uncoupling Protein 2 Inhibits Inflammatory Cytokines and Activates Cell Survival Factors after Cerebral Ischemia

  2012cites this paper
• Proliferación y apoptosis en células de músculo liso arteriales en cultivo

  2011cites this paper
• Notch signaling is involved in ovarian follicle development by regulating granulosa cell proliferation.

  2011cites this paper
• Fatty acids induce apoptosis in human smooth muscle cells depending on chain length, saturation, and duration of exposure.

  2009cites this paper
• Cellular and Biochemical Regulation of Cdc25A Phosphatase by Nitrosative Stress

  2008cites this paper
• Expression of cell-cycle-regulating genes in the development of atherosclerosis in Japanese quail (Coturnix japonica).

  2007cites this paper
• Evidence that insulin‐like growth factor‐1 requires protein kinase C‐ɛ, PI3‐kinase and mitogen‐activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis

  2005cites this paper
• The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells.

  2005cites this paper
• Subcellular localisation of Cdc25A determines cell fate

  2004cites this paper
• Subcellular localisation of Cdc25A determines cell fate

  2004cites this paper
• Anàlisi de l'expressió de NOR-1 en les cèl.lules musculars llises i de la seva implicació en la proliferació cel.lular

  2004cites this paper
• Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation

  2003cites this paper
• Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapy.

  2003cites this paper
• Human Vascular Smooth Muscle Cells From Restenosis or In-Stent Stenosis Sites Demonstrate Enhanced Responses to p53: Implications for Brachytherapy and Drug Treatment for Restenosis

  2002cites this paper
• c-myc activation in early coronary lesions in experimental hypercholesterolemia.

  2001cites this paper
• Atherosclerosis: cell biology and lipoproteins.

  2001cites this paper
• DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension.

  2000cites this paper
• The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease.

  2000cites this paper
• The role of the mitochondrion in smooth muscle cell fate choices of proliferation versus apoptosis during vascular and cardiovascular diseases

  1999cites this paper